Concepedia
Statistics
Publications
19
Citations
1.1K
H-Index
17
Active since
1986
Affiliations
University of Hong Kong(Current)
Queen Mary Hospital
International Network for Cancer Treatment and Research
Chinese University of Hong Kong
Hong Kong Polytechnic University
Paul N. Cheng is an author at University of Hong Kong specializing in oncology, medicine, and molecular oncology.
Publications per year
1986–2022
Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function
Alexander Lercher, Anannya Bhattacharya, Alexandra Popa et al. · Immunity · 2019 · 128 citations · Full text
Life Sciences, Immunology, Molecular Biology +15
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
Thomas Yau, Paul N. Cheng, Pierre Chan et al. · Investigational New Drugs · 2012 · 105 citations · Full text
Medicine, Oncology, Pharmacology +14
Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis
Alan Tin‐Lun Lam, Gabriel Wong, Ho‐Yin Chow et al. · Pigment Cell & Melanoma Research · 2010 · 100 citations
Life Sciences, Biochemistry, Oncology +16
Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest
Gabriel Wong, Hiu‐Chi Chong, Paul N. Cheng et al. · Cancer Letters · 2009 · 86 citations
Life Sciences, Oncology, Pharmacology +15
Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes
Saif Sattar Al-Aqbi, Jennifer A. Higgins, William Boyle et al. · Scientific Reports · 2018 · 85 citations · Full text
Medicine, Biochemistry, Oncology +14
1–5 of 19